STAAR Act 2022-09-30 Introduced in House Strategies To Address Antimicrobial Resistance Act or the STAAR Act

This bill expands various initiatives to address antimicrobial resistance.

The bill reestablishes the interagency Antimicrobial Resistance Task Force to coordinate and develop efforts addressing antimicrobial resistance.

The Department of Health and Human Services must encourage health care facilities to implement antimicrobial stewardship programs to evaluate and improve the use of antimicrobial drugs.

The bill also requires the use of the National Healthcare Safety Network and similar surveillance systems to collect and report data about the usage of antimicrobial drugs, changes in resistance to such drugs, and other trends impacting patient outcomes.

Additionally, the bill increases nationwide efforts to monitor, research, and prevent the spread of infection from resistant organisms by

  • establishing the Antimicrobial Resistance Surveillance and Laboratory Network in at least seven geographic regions,
  • maintaining the Clinical Trials Network on Antimicrobial Resistance to conduct clinical research, and
  • requiring collaboration with state and local agencies that support health care facilities that focus on preventing the spread of antibiotic-resistant bacteria.
]]> text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.